Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Savor has launched its first commercial product—an animal-and-plant-free butter made directly from carbon dioxide and other gases using proprietary technology. The butter has been sampled at high-profile events with positive feedback on taste and functionality. The process is self-GRAS affirmed for US sales; regulatory filings are underway for broader markets. The platform aims to replace conventional fats with low-carbon alternatives at price parity within years
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Savor.